Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma
Abstract Background Gliosarcoma (GSM) is a distinct and aggressive variant of glioblastoma multiforme (GBM) with worse prognosis and few treatment options. It is often managed with the same treatment modalities with temozolomide (TMZ) as in GBM. However, the therapeutic benefits on GSM from such tre...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2021-03-01
|
| Serier: | BMC Cancer |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12885-021-08008-y |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
